Agate Pass Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$901K Sell
11,517
-6,548
-36% -$528K 0.33% 66
2026
Q1
$1.57M Sell
18,065
-720
-4% -$69K 0.61% 48
2025
Q4
$1.8M Sell
18,785
-1,300
-6% -$126K 0.67% 44
2025
Q3
$1.91M Sell
20,085
-3,009
-13% -$277K 0.73% 42
2025
Q2
$2.01M Sell
23,094
-442
-2% -$37.5K 0.83% 38
2025
Q1
$2.11M Buy
23,536
+3,790
+19% +$339K 0.9% 36
2024
Q4
$1.58M Buy
19,746
+745
+4% +$64.5K 0.71% 43
2024
Q3
$1.71M Sell
19,001
-850
-4% -$71.5K 0.85% 38
2024
Q2
$1.56M Sell
19,851
-42
-0.2% -$3.44K 0.83% 37
2024
Q1
$1.73M Buy
19,893
+979
+5% +$83.6K 0.93% 36
2023
Q4
$1.56M Sell
18,914
-1,055
-5% -$80.4K 0.9% 34
2023
Q3
$1.56M Sell
19,969
-380
-2% -$31.8K 1.06% 29
2023
Q2
$1.79M Buy
20,349
+2,029
+11% +$175K 1.09% 27
2023
Q1
$1.48M Buy
18,320
+751
+4% +$61.2K 0.97% 34
2022
Q4
$1.37M Buy
17,569
+3,045
+21% +$247K 0.97% 35
2022
Q3
$1.17M Buy
14,524
+1,065
+8% +$95.7K 0.9% 34
2022
Q2
$1.21M Buy
13,459
+583
+5% +$59.1K 0.85% 39
2022
Q1
$1.43M Buy
12,876
+975
+8% +$103K 0.89% 37
2021
Q4
$1.23M Buy
+11,901
New +$1.38M 0.77% 37

Other funds holding MDT

Agate Pass Investment Management's MDT Position: Q2 2026 in Review

Agate Pass Investment Management reduced its Medtronic (MDT) stake by 36% in Q2 2026, selling an estimated $528K and leaving 11,517 shares worth $901K. The position accounts for 0.33% of the portfolio, ranked #66.

Agate Pass Investment Management first reported a position in MDT in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.11M in Q1 2025. 606 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Agate Pass Investment Management held 11,517 shares of Medtronic worth $901K as of Q2 2026.
  • Agate Pass Investment Management sold 6,548 Medtronic shares in Q2 2026, an estimated $528K.
  • Medtronic made up 0.33% of Agate Pass Investment Management's portfolio in Q2 2026, its #66 holding.
  • Agate Pass Investment Management first reported a position in Medtronic in Q4 2021 and has held it in 19 quarters since.
  • Agate Pass Investment Management's Medtronic position peaked at $2.11M in Q1 2025.
  • 606 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Agate Pass Investment Management's 13F filing for Q2 2026, filed 8 Jul 2026.